Target type: biologicalprocess
Any DNA synthesis that is involved in UV-damage excision repair. [GO_REF:0000060, GOC:TermGenie, PMID:10704216]
UV-damage excision repair is a crucial cellular process that removes damaged DNA segments caused by ultraviolet (UV) radiation. This process involves several key steps:
1. **Damage Recognition:** Specialized proteins, such as the UV-damaged DNA binding protein (UV-DDB) and Xeroderma pigmentosum protein A (XPA), recognize the distorted DNA structure caused by UV damage, specifically pyrimidine dimers (thymine dimers being the most common).
2. **Excision of Damaged DNA:** An enzyme complex, known as the excision nuclease, removes the damaged DNA segment. This complex is composed of several proteins, including:
- **Excision repair cross-complementing rodent repair deficiency, complementation group 1 (ERCC1)**: Responsible for making the 5' incision.
- **ERCC4 (also known as XPF)**: Responsible for making the 3' incision.
- **ERCC5 (also known as XPG)**: Involved in the 3' incision for bulky lesions.
- **XPA** and **Replication protein A (RPA)**: Play a role in stabilizing the damaged DNA and facilitating the excision process.
3. **Gap Filling:** Once the damaged segment is removed, DNA polymerase fills the gap by inserting the correct nucleotides, using the undamaged strand as a template.
4. **Ligation:** Finally, DNA ligase seals the newly synthesized DNA fragment to the existing DNA strand, completing the repair process.
The specific steps involved in UV-damage excision repair can vary depending on the type of lesion and the proteins involved. However, the overall process involves recognizing the damage, removing the damaged segment, filling the gap with new DNA, and sealing the repair. This complex mechanism ensures the integrity of the genome and protects the cell from the harmful effects of UV radiation.'
"
Protein | Definition | Taxonomy |
---|---|---|
DNA polymerase alpha catalytic subunit | A DNA polymerase alpha catalytic subunit that is encoded in the genome of human. [PRO:DNx] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
digallic acid | digallic acid: structure given in first source | benzoate ester; gallate ester | |
foscarnet | Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity. | carboxylic acid; one-carbon compound; phosphonic acids | antiviral drug; geroprotector; HIV-1 reverse transcriptase inhibitor; sodium-dependent Pi-transporter inhibitor |
zidovudine triphosphate | |||
resveratrol | trans-resveratrol : A resveratrol in which the double bond has E configuration. | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
TTP | pyrimidine ribonucleoside 5'-triphosphate | ||
aphidicolin | aphidicolin : A tetracyclic diterpenoid that has an tetradecahydro-8,11a-methanocyclohepta[a]naphthalene skeleton with two hydroxymethyl substituents at positions 4 and 9, two methyl substituents at positions 4 and 11b and two hydroxy substituents at positions 3 and 9. An antibiotic with antiviral and antimitotical properties. Aphidicolin is a reversible inhibitor of eukaryotic nuclear DNA replication. Aphidicolin: An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells. | tetracyclic diterpenoid | antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite |
pnu183792 | PNU183792: structure in first source | ||
GS-443902 | GS-441524 triphosphate: intracellular active metabolite of remdesivir GS-443902 : An organic triphosphate that is GS-441524 in which the 5'-hydroxy group has been replaced by a triphosphate group. It is the active metabolite of remdesivir. | aromatic amine; C-nucleoside; nitrile; organic triphosphate; pyrrolotriazine | anticoronaviral agent; antiviral drug; drug metabolite |
n(2)-(4-n-butylphenyl) 2'-deoxyguanosine | N(2)-(4-n-butylphenyl) 2'-deoxyguanosine: RN & structure given in first source |